PANOPTIX | VIVITY
Contact your Alcon representative to today
* Based on worldwide sales of AcrySof PanOptix and AcrySof IQ Vivity and Clareon PanOptix and Clareon Vivity IOLs
* Defi ned as modifi ed Miyata grade 0, <25mv/mm
2
over 3 years (n=138), and over 9 years (n=20), respectively. PCIOL=Presbyopia Correcting IOL.
† Results from a prospective, randomized, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the
AcrySof
®
IQ Vivity
®
Extended Vision IOL and 113 with the AcrySof
®
IQ IOL with 6 months follow-up.
‡ Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or
more of the 5 ETDRS chart letters in the line were identifi ed correctly.
Learn more at ClareonIOL.com
# 1 T R I F O C A L A N D E D O F
L E N S E S I N T H E W O R L D*,
W I T H OV E R 4 M I L L I O N C O M B I N E D
I M P L A N T S W O R L D W I D E
1 - 3
CLAREON® PANOPTIX®
The fi rst and only trifocal IOL to
deliver a full range of vision and
exceptional clarity that lasts with
undeniable patient satisfaction
7,8*
CLAREON® VIVITY® The
fi rst and only non-di¢ ractive
PCIOL with monofocal-
quality distance visual acuity,
excellence intermediate vision
and functional near vision
4-6†‡
© 2024 Alcon Inc. 05/24 US-CLI-2400063
